BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31461707)

  • 1. Predictive Capabilities of Three Widely Used Pathology Classification Systems and a Simplified Classification (Beijing Classification) in Primary IgA Nephropathy.
    Duan SW; Mei Y; Liu J; Chen P; Li P; Chen YZ; Lin SP; Zhang XG; Liu JN; Sun XF; Xie YS; Cai GY; Liu SW; Wu J; Chen XM
    Kidney Blood Press Res; 2019; 44(5):928-941. PubMed ID: 31461707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy.
    Kang SH; Choi SR; Park HS; Lee JY; Sun IO; Hwang HS; Chung BH; Park CW; Yang CW; Kim YS; Choi YJ; Choi BS
    Nephrol Dial Transplant; 2012 Jan; 27(1):252-8. PubMed ID: 21606384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.
    Park KS; Han SH; Kie JH; Nam KH; Lee MJ; Lim BJ; Kwon YE; Kim YL; An SY; Kim CH; Doh FM; Koo HM; Oh HJ; Kang SW; Choi KH; Jeong HJ; Yoo TH
    Hum Pathol; 2014 Feb; 45(2):236-43. PubMed ID: 24439222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
    Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Crescent Formation in IgA Nephropathy - a Multicenter Validation Study.
    Park S; Baek CH; Park SK; Kang HG; Hyun HS; Park E; Han SH; Ryu DR; Kim DK; Oh KH; Joo KW; Kim YS; Moon KC; Chin HJ; Lee H
    Kidney Blood Press Res; 2019; 44(1):22-32. PubMed ID: 30808840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
    Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy.
    Yu F; Zhu X; Yuan S; Chen X; Li Z; Qu Z; Liu H; Sun L; Liu F
    Ann Med; 2021 Dec; 53(1):587-595. PubMed ID: 33825605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of nephrotic IgA nephropathy according to the Oxford classification.
    Moriyama T; Nakayama K; Iwasaki C; Ochi A; Tsuruta Y; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
    Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat renal biopsy improves the Oxford classification-based prediction of immunoglobulin A nephropathy outcome.
    Jullien P; Laurent B; Berthoux F; Masson I; Dinic M; Claisse G; Thibaudin D; Mariat C; Alamartine E; Maillard N
    Nephrol Dial Transplant; 2020 Jul; 35(7):1179-1186. PubMed ID: 30445530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of the Oxford classification of IgA nephropathy to predict renal outcome].
    Peng YH; Su Y; Zhao YJ; Lin CN; Sun GF; Li H; Yu Y; Huang QY; Ye W; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):102-7. PubMed ID: 23469800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults.
    Lee H; Yi SH; Seo MS; Hyun JN; Jeon JS; Noh H; Han DC; Hwang SD; Jin SY; Kwon SH
    Korean J Intern Med; 2012 Sep; 27(3):293-300. PubMed ID: 23019394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.
    Saleem N; Nasir H; Anwar F; Aziz M; Khurshid K; Bashir S; Khan A
    Int Urol Nephrol; 2024 Jan; 56(1):345-353. PubMed ID: 37378850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
    Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
    Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
    Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
    J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of IgA nephropathy patients with different proportions of crescents.
    Zhang W; Zhou Q; Hong L; Chen W; Yang S; Yang Q; Chen W; Yu X
    Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.